A series of fifteen silver (I) quinoline complexes Q1–Q15 have been synthesized and studied for their biological activities. Q1–Q15 were synthesized from the reactions of quinolinyl Schiff base derivatives L1–L5 (obtained by condensing 2-quinolinecarboxaldehyde with various aniline derivatives) with AgNO3, AgClO4 and AgCF3SO3. Q1–Q15 were characterized by various spectroscopic techniques and the structures of [Ag(L1)2]NO3Q1, [Ag(L1)2]ClO4Q6, [Ag(L2)2]ClO4Q7, [Ag(L2)2]CF3SO3Q12 and [Ag(L4)2]CF3SO3Q14 were unequivocally determined by single crystal X-ray diffraction analysis. In vitro antimicrobial tests against Gram-positive and Gram-negative bacteria revealed the influence of structure and anion on the complexes′ moderate to excellent antibacterial activity. In vitro antioxidant activities of the complexes showed their good radical scavenging activity in ferric reducing antioxidant power (FRAP). Complexes with the fluorine substituent or the thiophene or benzothiazole moieties are more potent with IC50 between 0.95 and 2.22 mg/mL than the standard used, ascorbic acid (2.68 mg/mL). The compounds showed a strong binding affinity with calf thymus-DNA via an intercalation mode and protein through a static quenching mechanism. Cytotoxicity activity was examined against three carcinoma cell lines (HELA, MDA-MB231, and SHSY5Y). [Ag(L2)2]ClO4Q7 with a benzothiazole moiety and [Ag(L4)2]ClO4Q9 with a methyl substituent had excellent cytotoxicity against HELA cells.
1 January 2021 in Journal of Inorganic Biochemistry
Transition metal-based drugs have shown to be good therapeutic agents and in the same effort, our work has continued the search for even better ones. Four pyridinyl Schiff bases (Ea–Ed) and their silver(I) nitrate, perchlorate, and triflate complexes (1–12) were synthesized and characterized by elemental analysis, FT-IR, ESI-MS, UV-Vis, 1H and 13C NMR spectroscopy, and single-crystal X-ray diffraction. The analysis confirmed a linear geometry around the Ag(I) center for all complexes in the solution, and a T-shaped geometry for complexes 10 and 12 in the solid-state. The newly synthesized compounds were screened for their in vitro anticancer, antioxidant, and antimicrobial activities. In addition, their interactions with calf thymus-DNA (CT-DNA) and bovine serum albumin (BSA) were also studied. Complexes possessing either methyl substituent or the thiazole moiety showed better in vitro antimicrobial activity against the tested bacteria, especially against Gram-negative bacteria. The anions ClO4− and CF3SO3− were observed to have some influence on the antimicrobial activities also. Effective scavenging activity in FRAP assay was observed for complexes with OH− or F− as substituents with IC50 values between 0.79 and 2.02 mg mL−1. The complexes were subjected to DNA and BSA binding studies. The complexes bound to CT-DNA either via intercalation or groove binding mode with significant binding constants for complexes whose ligands bore OH− substituent. The complexes displayed moderate to high binding affinity to BSA and again the influence of the fluoro and hydroxyl substituent or thiazole moiety were noted to influence the interactions. Complexes 4 and 8 were more cytotoxic against HELA (cervical cancer cell line) compared to MDA-MB231 (breast cancer cell line) and SHSY5Y (neuronal cancer cell line), with two-fold more potent cytotoxic activity than the reference cisplatin. The complexes, as such, might be potential anticervical cancer agents.